Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)-1-piperazinyl)-, Hydrochloride (1:1)
2. 5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide
3. 68843, Emd
4. Emb 68843
5. Emb-68843
6. Emb68843
7. Emd 68843
8. Hcl, Vilazodone
9. Hydrochloride, Vilazodone
10. Viibryd
11. Vilazodone
12. Vilazodone Hcl
1. 163521-08-2
2. Vilazodone Hcl
3. Viibryd
4. Vilazodone (hydrochloride)
5. Emd-68843
6. Emd 68 843
7. Vilazodone Hydrochloride [usan]
8. 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide Hydrochloride
9. Emd 68843
10. U8htx2gk8j
11. Sb659746-a
12. 163521-08-2 (hcl)
13. Chebi:70705
14. Sb659746a
15. 5-[4-[4-(5-cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide Hydrochloride
16. Sb 659746a
17. Sb-659746a
18. Sb-659746-a
19. Vilazodone Hydrochloride (usan)
20. 5-(4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl)benzofuran-2-carboxamide, Hydrochloride
21. 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide Hydrochloride
22. 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)-1-piperazinyl)-, Hydrochloride (1:1)
23. 5-(4-(4-(5-cyano-1h-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide Monohydrochloride
24. 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;hydrochloride
25. 5-{4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide Hydrochloride
26. Unii-u8htx2gk8j
27. Vilazodonei
28. 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-piperazinyl]-, Hydrochloride (1:1)
29. Viibryd (tn)
30. Vilazodonehydrochloride
31. Vilazodone Monohydrochloride
32. Schembl867358
33. Chembl1615374
34. Dtxsid80936833
35. Bcp11496
36. Emd68843
37. Mfcd00940014
38. S4259
39. Vilazodone Hydrochloride [mi]
40. Akos024464039
41. Ccg-213313
42. Cs-0549
43. Vilazodone Hydrochloride [mart.]
44. Vilazodone Hydrochloride [vandf]
45. Vilazodone Hydrochloride [who-dd]
46. 5-{4-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboximidic Acid--hydrogen Chloride (1/1)
47. Ac-25885
48. As-74699
49. Emd 68843;sb659746a
50. Hy-14261
51. Vilazodone Hydrochloride, >=98% (hplc)
52. A3919
53. Sw219887-1
54. V0149
55. Vilazodone Hydrochloride [orange Book]
56. D09699
57. 521v128
58. J-525160
59. Q27139037
60. 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine Hydrochloride
61. 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)piperazine Hydrochloride
62. 1-[4-(5-cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine Hydrochloride
63. 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2carboxamide Hydrochloride
64. 5-[4-[4-(5-cyano-1h-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxamide Hydrochloride
65. 4-(2-carbamoyl-1-benzofuran-5-yl)-1-[4-(5-cyano-1h-indol-3-yl)butyl]piperazin-1-ium Chloride
66. Vilazodone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 478.0 g/mol |
---|---|
Molecular Formula | C26H28ClN5O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 477.1931528 g/mol |
Monoisotopic Mass | 477.1931528 g/mol |
Topological Polar Surface Area | 102 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 729 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Viibryd |
PubMed Health | Vilazodone (By mouth) |
Drug Classes | Antidepressant |
Drug Label | VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl), a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist.Vilazodone HCl is 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)... |
Active Ingredient | Vilazodone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 40mg; 20mg |
Market Status | Prescription |
Company | Forest Labs |
2 of 2 | |
---|---|
Drug Name | Viibryd |
PubMed Health | Vilazodone (By mouth) |
Drug Classes | Antidepressant |
Drug Label | VIIBRYD Tablets for oral administration contain polymorph Form IV vilazodone hydrochloride (HCl), a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist.Vilazodone HCl is 2-benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)... |
Active Ingredient | Vilazodone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 40mg; 20mg |
Market Status | Prescription |
Company | Forest Labs |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
Serotonin 5-HT1 Receptor Agonists
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?